ARG43739

anti-SARS-CoV-2 Spike ECD antibody [B004] (azide free)

anti-SARS-CoV-2 Spike ECD antibody [B004] (azide free) for ELISA,Neutralizing,Western blot and Virus

Overview

Product Description Human Monoclonal antibody recognizesSARS-CoV-2 Spike (ECD)
Tested Reactivity Virus
Tested Application ELISA, Neut, WB
Host Human
Clonality Monoclonal
Clone B004
Target Name SARS-CoV-2 Spike (ECD)
Antigen Species Virus
Immunogen Recombinant fragment of SARS-CoV-2 Spike protein ECD region.
Conjugation Un-conjugated
Alternate Names SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein

Application Instructions

Application Suggestion
Tested Application Dilution
ELISA1:160000 (ECD protein)
NeutAssay-dependent
WB1:500 - 1000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity purification with immunogen.
Buffer PBS
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Gene Symbol S
Gene Full Name SARS-CoV-2 Spike (ECD)
Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 Spike Protein derived from 2019-nCoV is composed of S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.
Highlight Related products:
SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Anti-Rabbit IgG secondary antibodies;
Related news:
HMGB1, a biomarker and therapeutic target in COVID-19